Home
Scholarly Works
Gemcitabine/carboplatin (GC) vs. carboplatin (C)...
Conference

Gemcitabine/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA).: Results of a Gynecologic Cancer Intergroup randomized phase III trial of the AGO OVAR, the NCICCTG and the EORTC GCG.

Authors

Pfisterer J; Plante M; Vergote I; Du Bois A; Wagner U; Hirte H; Lacave AJ; Stähle A; Kimmig R; Eisenhauer E

Volume

22

Pagination

pp. 450S-450S

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

July 15, 2004

Name of conference

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

LA, New Orleans

Conference start date

June 5, 2004

Conference end date

June 8, 2004

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

14

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team